gelsemium boiron xmk pilules
boiron - gelsemium sempervirens xmk 1 % - pillules - xmk - gelsemium xmk 1 %
gelsemium boiron 9ch pilules single-dose cont.
boiron - gelsemium 9ch 1 % - pillules in single-dose container - 9ch - gelsemium 9ch 1 %
gelsemium boiron 12ch pilules single-dose cont.
boiron - gelsemium 12ch 1 % - pillules in single-dose container - 12ch - gelsemium 12ch 1 %
gelsemium boiron 15ch pilules single-dose cont.
boiron - gelsemium 15ch 1 % - pillules in single-dose container - 15ch - gelsemium 15ch 1 %
gelsemium boiron 30ch pilules single-dose cont.
boiron - gelsemium 30ch 1 % - pillules in single-dose container - 30ch - gelsemium 30ch 1 %
gelsemium boiron 200k pilules single-dose cont.
boiron - gelsemium 200k 1 % - pillules in single-dose container - 200k - gelsemium 200k 1 %
gelsemium boiron mk pilules single-dose cont.
boiron - gelsemium mk 1 % - pillules in single-dose container - mk - gelsemium mk 1 %
gelsemium boiron xmk pilules single-dose cont.
boiron - gelsemium sempervirens xmk 1 % - pillules in single-dose container - xmk - gelsemium xmk 1 %
celontin- methsuximide capsule
parke-davis div of pfizer inc - methsuximide (unii: 0g76k8x6c0) (methsuximide - unii:0g76k8x6c0) - methsuximide 300 mg - celontin is indicated for the control of absence (petit mal) seizures that are refractory to other drugs. methsuximide should not be used in patients with a history of hypersensitivity to succinimides.
celontin ® (methsuximide capsules, usp)
farmea - methsuximide (unii: 0g76k8x6c0) (methsuximide - unii:0g76k8x6c0) - celontin is indicated for the control of absence (petit mal) seizures that are refractory to other drugs. methsuximide should not be used in patients with a history of hypersensitivity to succinimides.